Table 1.
Zones of Growth Inhibition (mm) after Treatment with Liquid Fractions of EOs | |||||||
---|---|---|---|---|---|---|---|
Strain | T-EO | TT-EO | B-EO | R-EO | E-EO | M-EO | L-EO |
2 | 56 (±9.29) | 8 (±6.66) | 8 (±1.15) | 41 (±0.58) | 0 (±0.00)/4.5 | 15 (±2.65) | 9 (±1.00) |
4 | 57(±16.50) | 9 (±1.15)/3.3 | 9 (±1.00) | 32 (±1.53) | 0 (±0.00)/4.8 | 14 (±2.31) | 8 (±1.15) |
5 | 36 (±4.04) | 15 (±2.89) | 10 (±1.00) | 40 (±3.46) | 8 (±0.58) | 12 (±2.31) | 9 (±1.00) |
6 | 35 (±3.06) | 15 (±1.73) | 8 (±0.58) | 32 (±0.58) | 8 (±1.15) | 11 (±1.53) | 12 (±2.65) |
7 | 55 (±13.87) | 20 (±10.79)/2.0 | 17 (±0.58) | 45 (±0.00) | 0 (±0.00)/6.7 | 13 (±1.73) | 9 (±1.15) |
10 | 61 (±2.31) | 14 (±1.15) | 9 (±2.31) | 35 (±0.58) | 0 (±0.00)/4.7 | 12 (±1.53) | 9 (±0.58) |
26 | 43 (±3.79) | 14 (±3.21) | 14 (±2.08) | 42 (±0.58) | 0 (±0.00)/5.7 | 15 (±0.58) | 9 (±1.00) |
27 | 60 (±13.86)/7.0 | 17 (±3.06) | 9 (±0.58) | 27 (±3.06) | 8 (±0.58)/2.0 | 13 (±2.00) | 10 (±1.15) |
28 | 39 (±6.56)/4.2 | 19 (±4.04) | 12 (±5.29) | 33 (±1.53) | 10 (±2.08)/2.5 | 15 (±1.15) | 12 (±2.00) |
29 | 51 (±5.13) | 13 (±1.15) | 9 (±1.53) | 38 (±3.21) | 3 (±5.20)/6.0 | 10 (±0.00) | 9 (±2.65) |
32 | 50 (±9.87) | 18 (±1.53) | 13 (±1.15) | 35 (±0.00) | 11 (±0.58) | 14 (±0.58) | 10 (±0.58) |
33 | 56 (±1.73)/17.0 | 24 (±1.53) | 18 (±0.00) | 51 (±1.00) | 0 (±0.00)/5.5 | 19 (±6.56)/6.5 | 14 (±2.89)/37.0 |
34 | 40 (±6.35) | 10 (±1.00) | 18 (±0.58) | 34 (±0.58) | 11 (±1.15) | 10 (±0.58) | 8 (±1.00) |
35 | 39 (±5.69) | 13 (±1.53) | 18 (±0.58) | 43 (±1.73) | 8 (±0.58)/2.3 | 14 (±3.61) | 9 (±0.58) |
ATCC 33591 | 43 (±3.06) | 17 (±3.51) | 9 (±0.00) | 37 (±0.00) | 3 (±4.62)/4.0 | 17 (±10.44) | 10 (±1.00) |
ATCC 6538 | 77(±12.58) | 30(±5.00) | 12 (±0.58) | 14 (±5.13) | 30(±0.5.8) | 14 (±3.21) | 10 (±0.58) |